PRAME and triple-negative breast carcinoma: Given the inherent mesenchymal phenotype of triple negative breast cancer cells, we determined the expression of the mesenchymal marker vimentin and the epithelial marker E-cadherin in relation to PRAME expression (Fig. 5a).